Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Communications Engineering
|
October 16, 2025
Programmable low-coherence wavefronts for enhanced localization
Burak Bilgin, Jy-Chin Liao, Hou-Tong Chen, et al.
Diagnostic Pathology
|
August 27, 2018
Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression
Hayriye Tatli Dogan, Merve Kiran, Burak Bilgin, et al.
Tuberkuloz Ve Toraks
|
September 28, 2021
[Clinical features of the ALK-mutant non-small cell lung cancer patients who received first-line alectinib treatment]
Mutlu Hızal, Burak Bilgin, Mehmet Ali Şendur, et al.
Scientific Reports
|
April 9, 2026
Machine learning-based prediction of recurrence after curative resection in non-small cell lung cancer
Ugur Ozberk, Selin Akturk Esen, Hilal Arslan, et al.
Journal of Cancer Research and Therapeutics
|
September 23, 2022
The relationship between adjuvant chemotherapy and thiol-disulfide compounds
Pınar Akyol, Didem Şener Dede, Burak Bilgin, et al.
Journal of Cancer Research and Therapeutics
|
March 19, 2019
Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization
Burak Bilgin, Mehmet Ali Nahit Sendur, Mutlu Hizal, et al.
Cancers
|
February 13, 2025
Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis
Furkan Ceylan, Mirmehdi Mehdiyev, Burak Bilgin, et al.
Journal of Cancer Research and Clinical Oncology
|
February 2, 2021
The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
Burak Bilgin, Mehmet Ali Nahit Şendur, Şebnem Yücel, et al.
International Journal of Cancer
|
October 4, 2025
Synergistic prognostic effect of the renin-angiotensin-aldosterone system and immune-checkpoint inhibition in advanced lung cancer: The SPERICIL study
Safa Can Efil, Sema Nur Ozsan Celebi, Beste Ozturk, et al.
Anti-Cancer Drugs
|
January 15, 2019
The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy
Tevhide Sahin, Omer Dizdar, Nuriye Ozdemir, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Communications Engineering
|
October 16, 2025
Programmable low-coherence wavefronts for enhanced localization
Burak Bilgin, Jy-Chin Liao, Hou-Tong Chen, et al.
Diagnostic Pathology
|
August 27, 2018
Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression
Hayriye Tatli Dogan, Merve Kiran, Burak Bilgin, et al.
Tuberkuloz Ve Toraks
|
September 28, 2021
[Clinical features of the ALK-mutant non-small cell lung cancer patients who received first-line alectinib treatment]
Mutlu Hızal, Burak Bilgin, Mehmet Ali Şendur, et al.
Scientific Reports
|
April 9, 2026
Machine learning-based prediction of recurrence after curative resection in non-small cell lung cancer
Ugur Ozberk, Selin Akturk Esen, Hilal Arslan, et al.
Journal of Cancer Research and Therapeutics
|
September 23, 2022
The relationship between adjuvant chemotherapy and thiol-disulfide compounds
Pınar Akyol, Didem Şener Dede, Burak Bilgin, et al.
Journal of Cancer Research and Therapeutics
|
March 19, 2019
Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization
Burak Bilgin, Mehmet Ali Nahit Sendur, Mutlu Hizal, et al.
Cancers
|
February 13, 2025
Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis
Furkan Ceylan, Mirmehdi Mehdiyev, Burak Bilgin, et al.
Journal of Cancer Research and Clinical Oncology
|
February 2, 2021
The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
Burak Bilgin, Mehmet Ali Nahit Şendur, Şebnem Yücel, et al.
International Journal of Cancer
|
October 4, 2025
Synergistic prognostic effect of the renin-angiotensin-aldosterone system and immune-checkpoint inhibition in advanced lung cancer: The SPERICIL study
Safa Can Efil, Sema Nur Ozsan Celebi, Beste Ozturk, et al.
Anti-Cancer Drugs
|
January 15, 2019
The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy
Tevhide Sahin, Omer Dizdar, Nuriye Ozdemir, et al.
Page
of 10